(S)-(+)-2-Chloromandelic Acidum CAS 52950-19-3 Intende ≥99.0% (HPLC)

Description:

Chemical Name: (S)-(+)-2-Chloromandelic Acid

Synonyma: 2-Chloro-L-Mandelic Acid

CAS: 52950-19-3

Aspectus: Crystallinus Powder Alba

Intenta: ≥99.0% (HPLC) (ex sicca basis)

Chiral Compounds, High Quality, Commercial Production


Product Detail

Related Products

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
(S)-(+)-2-Chloromandelic Acidum CAS: 52950-19-3
(R)-(-)-2-Chloromandelic Acidum CAS: 52950-18-2
2-Chloromandelic Acidum CAS: 10421-85-9
Chiral Compounds, High Quality, Commercial Production

Chemical Properties:

Nomen chemicum (S)-(+)-2-Chloromandelic Acid
Synonyma 2-Chloro-L-Mandelic Acid
CAS Number 52950-19-3
CATTUS Number RF-CC174
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C8H7ClO3
M. Pondus 186.59
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Crystallina pulveris alba
Humor (KF) ≤0.50%
Liquescens punctum 116.0~122.0℃
Imprimis Rotationes (20/D) +120.0°~+125.0°
Assay ≥99.0% (HPLC) (ex exaruit basis)
Test Standard Enterprise Standard
Consuetudinem Chiral Compositions;Pharmaceutical Medium

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

1

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est praecipuum fabricam et supplementum (S)-(+)-2-Acidi Chloromandelici (CAS: 52950-19-3) cum qualitate, Chiral Composita, Agentia Chiral Separatio, late in usu intermedia pharmaceutica et processus rudis materiae chiralis separationis.

(S)-(+)-2-Acid Chloromandelicum (CAS: 52950-19-3) adhiberi potest ut medium in synthesi Clopidogrel hydrogenii sulfati API.

Shanghai Ruifu Chemical Co, Ltd. magni ponderis munus agit in chymiae chiralae, societas commissa productioni compositionum chiralium.Nostri fructus a clientibus late laudantur.

Epistulam tuam hic scribe et mitte nobis